Share on LinkedInShare on LinkedIn

ARTICLE · 30 MARCH 2022

IM Cannabis Closes Three Strategic Acquisitions In Israel

Gowling WLG
Gowling WLG
Contributor
Gowling WLG

Gowling WLG

The firm The firm’s lawyers speak English, French, Russian and Ukrainian. The firm’s client base...

View firm profile
Explore more from Gowling WLG

On March 15, 2022, IM Cannabis Corp. ("IM Cannabis") (CSE: IMCC) (NASDAQ: IMCC) announced that it had completed three strategic acquisitions announced in 2021.

CanadaCannabis & Hemp

On March 15, 2022, IM Cannabis Corp. ("IM Cannabis") (CSE: IMCC) (NASDAQ: IMCC) announced that it had completed three strategic acquisitions announced in 2021. The acquisitions were completed through IMC Holdings Ltd., a wholly-owned subsidiary of IM Cannabis and I.M.C Pharma Ltd., IMC Holdings' wholly-owned subsidiary, following receipt of all requisite approvals, including from the Israeli Medical Cannabis Unit ("IMCU").

IMC Holdings successfully completed the acquisition of 51% of the outstanding ordinary shares of Revoly Trading and Marketing Ltd., dba Vironna. Vironna ranks among the top 10 single cannabis dispensing points in Israel and is one of the largest pharmacies in Israel serving the rapidly growing Arab consumer segment of the medical cannabis market.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from